Kenneth A. Ellenbogen on Muck Rack

Kenneth A. Ellenbogen

Henrico
As seen in: Nature, Wiley Online Library, Medscape, The New England Journal of Medicine, AHA/ASA Journals, Healio, Healio Cardiology, HMP Global Learning Network, JACC (Journal of the American College of Cardiology), Canadian Journal of Cardiology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kenneth A.

Contact Kenneth A., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

VT Ablation in High-Risk Patients: Risk Discussion Framework

|
By Roland R. Tilz, Kenneth A. Ellenbogen, Pier D. Lambiase
| arrhythmiaacademy.com
EHRA Congress 2026 — Dr Francesco Santoro (University of Foggia, Foggia, IT) joins us to explore how electrophysiologists can approach risk assessment and decision-making when considering catheter ablation in high-risk ventricular tachycardia patients — a population where the potential benefits of ablation must be carefully weighed against procedural complexity and patient frailty.
Open in Who Shared Issue with article?

Pulsed Field versus Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: 4-Year Outcomes in the ADVENT-LTO Study - Nature Medicine

|
By Vivek Y. Reddy, Edward P Gerstenfeld, Stavros E. Mountantonakis, Chinmay Patel, Kenneth A. Ellenbogen, John Harding Verified, Douglas Gibson, Andrea Natale, Jonathan W. Waks, Hugh Calkins, Sanjaya Gupta, Christopher Woods, William Whang, Frank A. Cuoco, David DeLurgio, Elizabeth Richards, Matthew Martens, Brad Sutton, Moussa Mansour, Marcos Daccarett
| Nature Verified
Abstract Pulsed field ablation (PFA) has proven to be a safe and effective non-thermal ablation modality for the treatment of atrial fibrillation (AF), but little outcome data beyond 1 year has been reported. Here, we present results from the ADVENT-LTO study, which provides extended follow-up of the ADVENT trial, the first randomized trial comparing PFA with conventional thermal ablation.
Open in Who Shared Issue with article?

Physiologic Pacing in Heart Failure | NEJM

|
By Kenneth A. Ellenbogen
| The New England Journal of Medicine Verified
Are you a member of an institution such as a university or hospital?Learn more about Institutional Access Notes Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. Supplementary Material Disclosure Forms (nejmra2415650_disclosures.pdf)
Open in Who Shared View Duplicates (3) Issue with article?
See all 38 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified